Gerald L. Ray & Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$2.85M Sell
35,110
-1,987
-5% -$157K 0.36% 69
2017
Q2
$2.98M Sell
37,097
-2,789
-7% -$220K 0.38% 66
2017
Q1
$3.13M Buy
39,886
+943
+2% +$75.3K 0.43% 61
2016
Q4
$3.07M Sell
38,943
-1,944
-5% -$157K 0.45% 58
2016
Q3
$3.64M Sell
40,887
-74
-0.2% -$6.99K 0.55% 48
2016
Q2
$3.92M Buy
40,961
+2,437
+6% +$243K 0.63% 47
2016
Q1
$4M Buy
38,524
+145
+0.4% +$14.1K 0.65% 43
2015
Q4
$3.75M Buy
38,379
+7,400
+24% +$725K 0.59% 42
2015
Q3
$2.99M Buy
30,979
+1,729
+6% +$182K 0.5% 54
2015
Q2
$3.07M Hold
29,250
0.47% 57
2015
Q1
$3.02M Sell
29,250
-52
-0.2% -$5.26K 0.45% 55
2014
Q4
$2.82M Sell
29,302
-65
-0.2% -$5.73K 0.43% 55
2014
Q3
$2.34M Buy
29,367
+52
+0.2% +$4.1K 0.38% 71
2014
Q2
$2.21M Sell
29,315
-567
-2% -$42.9K 0.38% 73
2014
Q1
$2.24M Sell
29,882
-450
-1% -$31.8K 0.41% 70
2013
Q4
$2.17M Hold
30,332
0.41% 65
2013
Q3
$1.72M Sell
30,332
-50
-0.2% -$2.98K 0.36% 72
2013
Q2
$1.74M Buy
+30,382
New +$1.76M 0.39% 70

Other funds holding CVS

Gerald L. Ray & Associates's CVS Position: Q3 2017 in Review

Gerald L. Ray & Associates reduced its CVS Health (CVS) stake by 5.4% in Q3 2017, selling an estimated $157K and leaving 35,110 shares worth $2.85M. The position accounts for 0.36% of the portfolio, ranked #69.

Gerald L. Ray & Associates first reported a position in CVS in Q2 2013 and has held it in 18 quarters since. The position peaked at $4M in Q1 2016. 1,531 funds tracked by Wall St. Rank hold CVS as of Q3 2017.

  • Gerald L. Ray & Associates held 35,110 shares of CVS Health worth $2.85M as of Q3 2017.
  • Gerald L. Ray & Associates sold 1,987 CVS Health shares in Q3 2017, an estimated $157K.
  • CVS Health made up 0.36% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #69 holding.
  • Gerald L. Ray & Associates first reported a position in CVS Health in Q2 2013 and has held it in 18 quarters since.
  • Gerald L. Ray & Associates's CVS Health position peaked at $4M in Q1 2016.
  • 1,531 funds tracked by Wall St. Rank held CVS Health as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.